Kerstin Stenson to Transforming Growth Factor alpha
This is a "connection" page, showing publications Kerstin Stenson has written about Transforming Growth Factor alpha.
Connection Strength
0.021
-
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study. Lancet Oncol. 2009 Mar; 10(3):247-57.
Score: 0.021
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.